Heron Therapeutics Inc vs Lamb Weston Holdings Inc — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Lamb Weston Holdings Inc trades at $46.42 (market cap $6.43B). The key difference: Lamb Weston Holdings Inc is far larger — about 70.3× Heron Therapeutics Inc's market cap, and Lamb Weston Holdings Inc pays a 3.26% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | LW | |
|---|---|---|
Market Cap | $91.46M | $6.43B |
Sector | Health | Consumer Staples |
52-Week High | $1.96 | $66.57 |
52-Week Low | $0.39 | $38.48 |
Enterprise Value | $189.36M | $10.40B |
Dividend Yield | — | 3.26% |
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. The company also has a small appetizer business that produces onion rings, mozzarella sticks, and cheese curds. Including joint ventures, 63% of fiscal 2022 revenue was U.S.-based, with the remainder stemming from Europe, Canada, Japan, China, Korea, Mexico, and several other countries. Lamb Weston's customer mix is estimated 58% quick-serve restaurants, 19% full-service restaurants, 8% other food services (hotels, commercial cafeterias, arenas, schools), and 16% retail. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Read more on LW →